{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T16:44:48Z","timestamp":1791045888935,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1016\/j.bbapap.2007.10.009","type":"journal-article","created":{"date-parts":[[2007,11,21]],"date-time":"2007-11-21T10:33:32Z","timestamp":1195641212000},"page":"143-149","source":"Crossref","is-referenced-by-count":42,"title":["Evaluation of 4,5,6,7-tetrahalogeno-1H-isoindole-1,3(2H)-diones as inhibitors of human protein kinase CK2"],"prefix":"10.1016","volume":"1784","author":[{"given":"A.G.","family":"Golub","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O. Ya.","family":"Yakovenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.O.","family":"Prykhod'ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.S.","family":"Lukashov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.G.","family":"Bdzhola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.M.","family":"Yarmoluk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbapap.2007.10.009_bib1","first-page":"573","article-title":"Protein kinase CK2 signal in neoplasia","volume":"16","author":"Tawfic","year":"2001","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.bbapap.2007.10.009_bib2","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1096\/fj.02-0473rev","article-title":"One-thousand-and-one substrates of protein kinase CK2?","volume":"17","author":"Meggio","year":"2003","journal-title":"FASEB J."},{"key":"10.1016\/j.bbapap.2007.10.009_bib3","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s11010-005-2952-0","article-title":"Modulation of death receptor mediated apoptosis by CK2","volume":"274","author":"Wang","year":"2005","journal-title":"Mol. Cell Biochem."},{"key":"10.1016\/j.bbapap.2007.10.009_bib4","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S0962-8924(02)02279-1","article-title":"Joining the cell survival squad: and emerging role for protein kinase CK2","volume":"12","author":"Ahmed","year":"2002","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.bbapap.2007.10.009_bib5","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.bbapap.2005.07.043","article-title":"Features and potentials of ATP-site directed CK2 inhibitors","volume":"1754","author":"Sarno","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbapap.2007.10.009_bib6","doi-asserted-by":"crossref","first-page":"7736","DOI":"10.1073\/pnas.0409818102","article-title":"Inhibition of protein kinase CK2 prevents the progression of glomerulonephritis","volume":"102","author":"Yamada","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbapap.2007.10.009_bib7","doi-asserted-by":"crossref","first-page":"4583","DOI":"10.1167\/iovs.04-0686","article-title":"Involvement of protein kinase CK2 in angiogenesis and retinal neovascularization","volume":"45","author":"Ljubimov","year":"2004","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.bbapap.2007.10.009_bib8","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1021\/jm060112m","article-title":"Identification of ellagic acid as potent inhibitor of protein kinase CK2: a successful example of a virtual screening application","volume":"49","author":"Cozza","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbapap.2007.10.009_bib9","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1021\/jm030827e","article-title":"Discovery of a potent and selective protein kinase CK2 inhibitor by high-throughput docking","volume":"46","author":"Vangrevelinghe","year":"2003","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbapap.2007.10.009_bib10","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1042\/bj20030674","article-title":"Biochemical and three-dimensional-structural study of the specific inhibition of protein kinase CK2 by [5-Oxo-5,6-dihydroindolo-(1,2-a)quinazolin-7-yl]acetic acid (IQA)","volume":"374","author":"Sarno","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbapap.2007.10.009_bib11","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1006\/bbrc.1995.1354","article-title":"Halogenated benzimidazoles and benzotriazoles as selective inhibitors of protein kinases CK I and CK II from Saccharomyces cerevisiae and other sources","volume":"208","author":"Szyszka","year":"1995","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbapap.2007.10.009_bib12","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.bbapap.2005.07.039","article-title":"Tetrabromobenzotriazole (TBBt) and tetrabromobenzimidazole (TBBz) as selective inhibitors of protein kinase CK2: evaluation of their effects on cells and different molecular forms of human CK2","volume":"1754","author":"Zien","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbapap.2007.10.009_bib13","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0006-291X(03)00928-8","article-title":"Selectivity of 4,5,6,7-tetrabromobenzimidazole as an ATP-competitive potent inhibitor of protein kinase CK2 from various sources","volume":"306","author":"Zien","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbapap.2007.10.009_bib14","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.chembiol.2005.08.015","article-title":"Inspecting the structure-activity relationship of protein kinase CK2 inhibitors derived from tetrabromo-benzimidazole","volume":"12","author":"Battistutta","year":"2005","journal-title":"Chem. Biol."},{"key":"10.1016\/j.bbapap.2007.10.009_bib15","first-page":"129","article-title":"Tetrabromocinnamic acid (TBCA) and related compounds represent a new class of specific protein kinase CK2 inhibitors","volume":"8","author":"Pagano","year":"2006","journal-title":"Chem. Biochem."},{"key":"10.1016\/j.bbapap.2007.10.009_bib16","doi-asserted-by":"crossref","first-page":"6443","DOI":"10.1021\/jm050048t","article-title":"Evaluation of 3-carboxy-4(1H)-quinolones as inhibitors of human protein kinase CK2","volume":"49","author":"Golub","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbapap.2007.10.009_bib17","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0163-7258(02)00185-7","article-title":"Toward the rational design of protein kinase casein kinase-2 inhibitors","volume":"93","author":"Sarno","year":"2002","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbapap.2007.10.009_bib18","doi-asserted-by":"crossref","first-page":"12931","DOI":"10.1021\/bi048999g","article-title":"Inhibition of protein kinase CK2 by condensed polyphenolic derivatives. An in vitro and in vivo study","volume":"43","author":"Meggio","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbapap.2007.10.009_bib19","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1126\/science.8451640","article-title":"Structure-based discovery of inhibitors of thymidylate synthase","volume":"259","author":"Shoichet","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.bbapap.2007.10.009_bib20","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1021\/bi00063a007","article-title":"Inhibition of the fusion-inducing conformational change of influenza hemagglutinin by benzoquinones and hydroquinones","volume":"32","author":"Bodian","year":"1993","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbapap.2007.10.009_bib21","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1073\/pnas.90.8.3583","article-title":"Structure-based inhibitor design by using protein models for the development of antiparasitic agents","volume":"90","author":"Ring","year":"1993","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbapap.2007.10.009_bib22","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1023\/A:1011115820450","article-title":"DOCK 4.0: search strategies for automated molecular docking of flexible molecule databases","volume":"15","author":"Ewing","year":"2001","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.bbapap.2007.10.009_bib23","first-page":"52","article-title":"The new method of distribution integrals evaluations for high throughput virtual screening","volume":"1","author":"Yakovenko","year":"2007","journal-title":"Ukrainica Bioorganica Acta"},{"key":"10.1016\/j.bbapap.2007.10.009_bib24","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/s008940100045","article-title":"GROMACS 3.0: a package for molecular simulation and trajectory analysis","volume":"7","author":"Lindahl","year":"2001","journal-title":"J. Mol. Mod."},{"key":"10.1016\/j.bbapap.2007.10.009_bib25","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.chembiol.2003.11.010","article-title":"GSK-3 selective inhibitors derived from Tyrian purple indirubins","volume":"10","author":"Meijer","year":"2003","journal-title":"Chem. & Biol"},{"key":"10.1016\/j.bbapap.2007.10.009_bib26","first-page":"78","volume":"vol. 27","author":"Shriner","year":"1947"},{"key":"10.1016\/j.bbapap.2007.10.009_bib27","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1110\/ps.19601","article-title":"Structural features underlying selective inhibition of protein kinase CK2 by ATP site-directed tetrabromo-2-benzotriazole","volume":"10","author":"Battistutta","year":"2001","journal-title":"Protein Sci"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570963907002634?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570963907002634?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,2]],"date-time":"2019-01-02T17:23:52Z","timestamp":1546449832000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570963907002634"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S1570963907002634"],"URL":"https:\/\/doi.org\/10.1016\/j.bbapap.2007.10.009","relation":{},"ISSN":["1570-9639"],"issn-type":[{"value":"1570-9639","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]}}}